PARIS
Welch Allyn, a leading manufacturer of frontline medical products and solutions including vital signs monitors and spot check devices, announced today that it had formed a new partnership with Sensitron Inc., a leader in medical device connectivity and data management, and its exclusive distributors in Europe, U.K. and the Middle East. This agreement will provide a solution for ensuring that key vital signs data are captured with Sensitron's careTrends® and automatically sent to a dedicated server and an electronic medical record (EMR) when available. This solution helps to reduce transcription errors as well as time lag between the capture and posting of data.
This partnership will help clinicians meet their qualitative and quantitative objectives-giving them the right information at the right time. Together, Welch Allyn and Sensitron will provide nurses and clinicians with technology that will help them deliver an enhanced standard of clinical care, as well as both time and budget savings. Welch Allyn's extensive range of traditional vital signs monitors and spot checking devices can either be wirelessly enabled or hard-wired by Sensitron's careTrends®.
"We believe that our partnership with Sensitron will provide the best of both worlds, data capture and data management, offering significant benefit to the patients, nurses and clinicians," said Pascal Gand, product development director at Welch Allyn. "This is particularly exciting in this vital signs domain, where very few connected solutions exist today."
"We are very pleased by this agreement," said Garry Stephen, cofounder and CEO of Sensitron Europe. "It will provide users of Welch Allyn vital signs monitors with immediate and reliable data for quicker and better-informed medical decisions, while allowing medical staff to dedicate more time to their patients."
About Sensitron, Inc. (http://www.sensitron.net)
Sensitron, Inc., based in San Mateo, Calif., is an international wireless healthcare innovations company that has developed careTrends® for med-surg units and Critical careTrends™ for critical/intensive care units-both of which communicate vital signs and other data from wirelessly-enabled, legacy point-of-care medical devices at the patient bedside. Sensitron, Inc. was founded in 1997, is a privately-held company and is expanding internationally via channel partners.
careTrends is a registered trademark and Critical careTrends is a trademark of Sensitron, Inc.
Über Welch Allyn:
Gegründet im Jahre 1915 und mit Hauptsitz in Skaneateles Falls, NY, USA, ist Welch Allyn einer der weltweit führenden Hersteller für fortschrittliche medizinische Diagnostikinstrumente und einer umfassenden Produktpalette an digitalen und Connectivity-Lösungen. Mit 2.500 Mitarbeitern in 26 Ländern ist Welch Allyn darauf spezialisiert, Ärzte und Pflegepersonal auf der ganzen Welt dabei zu unterstützen, die bestmögliche Patientenversorgung zu gewährleisten, indem das Unternehmen innovative Produkte, neueste Technologien und Spitzenlösungen produziert, mit denen mehr Patienten behandelt, mehr Krankheiten diagnostiziert und mehr Leben verbessert werden können. Weitere Informationen über Welch Allyn und das Angebot an Connectivity-Produkten und ‑Lösungen, finden Sie unter www.welchallyn.com.
Abdruck honorarfrei - Belegexemplar erbeten
Anzahl der Zeichen (mit Leerzeichen): 5677
©2010 Alle Rechte vorbehalten.
